Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers
Purpose The ability of two semi-mechanistic simulation approaches to predict the systemic
pharmacokinetics (PK) of inhaled corticosteroids (ICSs) delivered via dry powder inhalers …
pharmacokinetics (PK) of inhaled corticosteroids (ICSs) delivered via dry powder inhalers …
[HTML][HTML] In Vitro to ex Vivo/In Vivo Correlation (IVIVC) of dissolution kinetics from inhaled particulate solutes using air/blood barrier models: Relation between in vitro …
P Gerde, M Malmlöf, E Selg - Journal of Aerosol Science, 2021 - Elsevier
Correlating data from in vitro dissolution testing of inhaled particulate pharmaceuticals or air
pollutants with the dissolution and distribution to the blood circulation of the same aerosols …
pollutants with the dissolution and distribution to the blood circulation of the same aerosols …
[HTML][HTML] Optimization of the Transwell® System for Assessing the Dissolution Behavior of Orally Inhaled Drug Products through In Vitro and In Silico Approaches
The aim of this study was to further evaluate and optimize the Transwell® system for
assessing the dissolution behavior of orally inhaled drug products (OIDPs), using fluticasone …
assessing the dissolution behavior of orally inhaled drug products (OIDPs), using fluticasone …
Formulation strategies for pulmonary delivery of poorly soluble drugs
Poorly water‐soluble drugs represent the major part of the current and future market. Drug
insolubility could impair the absorption through biological membranes and/or the …
insolubility could impair the absorption through biological membranes and/or the …
[HTML][HTML] Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products
The aim of the study was to develop a robust and standardized in vitro dissolution
methodology for orally inhaled drug products (OIDPs). An aerosol dose collection (ADC) …
methodology for orally inhaled drug products (OIDPs). An aerosol dose collection (ADC) …
[PDF][PDF] The inhalation ad hoc advisory panel for the USP performance tests of inhalation dosage forms
VP Shah, MJ Smurthwaite, JM Veranth… - Pharmaceutical …, 2008 - researchgate.net
ABSTRACT The US Pharmacopeia (USP) contains standards for tests, procedures, and
acceptance criteria for inhalation dosage forms that are administered orally and intranasally …
acceptance criteria for inhalation dosage forms that are administered orally and intranasally …
In vitro and in vivo testing methods for respiratory drug delivery
RU Agu, MI Ugwoke - Expert opinion on drug delivery, 2011 - Taylor & Francis
Importance of the field: Successful respiratory drug delivery for local and systemic purposes
is predicated on the availability of in vitro and in vivo methods for determining drug delivery …
is predicated on the availability of in vitro and in vivo methods for determining drug delivery …
Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension
K Šimková, B Joost, G Imanidis - European Journal of Pharmaceutics and …, 2020 - Elsevier
We combined high-energy wet media milling and spray drying to engineer dry powders for
inhalation consisting of geometrically large, low-density particles with superior aerodynamic …
inhalation consisting of geometrically large, low-density particles with superior aerodynamic …
In Vitro Aqueous Fluid-Capacity-Limited Dissolution Testing of Respirable Aerosol Drug Particles Generated from Inhaler Products
D Arora, KA Shah, MS Halquist, M Sakagami - Pharmaceutical research, 2010 - Springer
Purpose To develop a unique in vitro aqueous fluid-capacity-limited dissolution system for
the kinetic assessment of respirable aerosol drug particles from inhaler products. Methods …
the kinetic assessment of respirable aerosol drug particles from inhaler products. Methods …
A novel method for assessing dissolution of aerosol inhaler products
NM Davies, MR Feddah - International journal of pharmaceutics, 2003 - Elsevier
Glucocorticoids administered by inhalation remain a first-line treatment of patients with
asthma allergic rhinitis and advanced chronic obstructive pulmonary disease. Budesonide …
asthma allergic rhinitis and advanced chronic obstructive pulmonary disease. Budesonide …